Form S-1/A BOA Acquisition Corp. II For: 5 May

Viridian Therapeutics stock surges on positive trial results

Investing.com · News 14m ago

Arrowhead licenses MASH drug candidate to Madrigal for $1B

Investing.com · News 14m ago

Bionano reports 56% jump in rare disease research publications

Investing.com · News 14m ago

J&J’s JNJ-4804 shows improved outcomes in bowel disease trial

Investing.com · News 14m ago

J&J’s Tremfya shows efficacy in fistulizing Crohn’s disease

Investing.com · News 14m ago

OpenWorld to tokenize equity on Figure’s blockchain platform

Investing.com · News 14m ago

AbbVie presents IBD data at digestive disease conference

Investing.com · News 14m ago

Atkore Reports Wider Q2 Loss, Maintains FY26 Outlook; Stock Up

NASDAQ · Markets 16m ago

Palantir falls premarket; ServiceNow, PayPal rise

Investing.com · Investing_news 16m ago

Southwest Gas Holdings, Inc. Reports Increase In Q1 Profit

NASDAQ · Markets 18m ago